Publications by authors named "Kate van Brunt"

Claim this Profile
I
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Healthcare Resource Utilization and Associated Costs Among People With Cystic Fibrosis in the US: A Retrospective Claims Analysis.
Michael S Schechter, Natalia Sabater-Anaya, Gerry Oster, Derek Weycker, Hongsheng Wu, Kate Van Brunt

Pulm Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS.
Tim Lee, Gregory S Sawicki, Josje Altenburg, Stefanie J Millar, Jessica Morlando Geiger, Kate Van Brunt

J Cyst Fibros· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor.
Isabelle Fajac, Cori Daines, Isabelle Durieu, Jennifer L Goralski, Harry Heijerman, Kate Van Brunt

J Cyst Fibros· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease burden in people with cystic fibrosis heterozygous for F508del and a minimal function mutation.
Gregory S Sawicki, Kate Van Brunt, Jason Booth, Evan Bailey, Stefanie J Millar

J Cyst Fibros· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Trend of High-Dose Insulin Usage Among Patients with Diabetes in the UK: A Retrospective Study.
Iskandar Idris, Xiaomei Peng, Xuanyao He, Dongju Liu, Elemer Balogh, Kate Van Brunt

Diabetes Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation.
William J Valentine, Kate Van Brunt, Kristina S Boye, Richard F Pollock

Appl Health Econ Health Policy· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Outcomes in Patients with Type 2 Diabetes Treated with Dulaglutide Added to Titrated Insulin Glargine (AWARD-9).
Maria Yu, Kate Van Brunt, Zvonko Milicevic, Oralee Varnado, Kristina S Boye

Clin Ther· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behaviours, thoughts and perceptions around mealtime insulin usage and wastage among people with type 1 and type 2 diabetes mellitus: A cross-sectional survey study.
Kate Van Brunt, Riccardo Pedersini, Jillian Rooney, Sheila M Corrigan

Diabetes Res Clin Pract· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin.
Kate van Brunt, Bradley Curtis, Tibor Ivanyi, Elemer Balogh, Corina Chalkiadaki

Diabetes Ther· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin.
Tao Wang, Kenneth A Conrad, Kate van Brunt, Tina M Rees

J Diabetes Sci Technol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes.
Elizabeth L Eby, Kate Van Brunt, Cynthia Brusko, Bradley Curtis, Maureen J Lage

Clin Interv Aging· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin dosing and outcomes among commercially insured patients with type 2 diabetes in the United States.
Elizabeth L Eby, Kate Van Brunt, Cynthia Brusko, Bradley Curtis, Maureen J Lage

Clin Ther· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes.
Glenn Matfin, Kate Van Brunt, Alan G Zimmermann, Rebecca Threlkeld, Debra A Ignaut

J Diabetes Sci Technol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health state utilities for skeletal-related events secondary to bone metastases.
Louis S Matza, Karen Chung, Kate Van Brunt, John E Brazier, Ada Braun

Eur J Health Econ· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin use in long term care settings for patients with type 2 diabetes mellitus: a systematic review of the literature.
Kate Van Brunt, Bradley Curtis, Keyla Brooks, Alexandra Heinloth, Rita de Cassia Castro

J Am Med Dir Assoc· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases.
Louis S Matza, Ze Cong, Karen Chung, Alison Stopeck, Katia Tonkin, Kate Van Brunt

Patient Prefer Adherence· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases.
Louis S Matza, Lesley J Fallowfield, Karen C Chung, Brooke M Currie, Kate Van Brunt

Support Care Cancer· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.
Kristina S Boye, Louis S Matza, Kimberly N Walter, Kate Van Brunt, Andrew C Palsgrove

Eur J Health Econ· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences related to attention-deficit/hyperactivity disorder and its treatment.
Kate Van Brunt, Louis S Matza, Peter M Classi, Joseph A Johnston

Patient Prefer Adherence· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis